CYTOKINETICS INC — Director's Dealing 2021

Oct 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-10-19

Reporting Person: Jaw Ching (SVP Finance & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-19	Common Stock	S	35687	$35.7325	Disposed	53064	Direct

Footnotes

F1: Amount of securities beneficially owned following reported transaction has been adjusted by 182 shares representing shares purchased pursuant to ESPP but that have not been previously reported.
Reporting persons Form 4 filed on March 09, 2021 erroneously stated that the reported 88,492 shares owned following reporting persons transaction on March 08, 2021 included 727 shares of common stock purchased pursuant to ESPP, but in fact only 545 shares of common stock purchased pursuant to ESPP were included in that 88,492 share total.

F2: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 15, 2021.

F3: Includes 804 shares of common stock purchased pursuant to the Issuers 2015 Employee Stock Purchase Plan (ESPP).